实用肝脏病杂志 ›› 2024, Vol. 27 ›› Issue (4): 627-630.doi: 10.3969/j.issn.1672-5069.2024.04.034

• 肝血管瘤 • 上一篇    下一篇

CT增强扫描评估肝血管瘤血供分型和肝动脉栓塞治疗疗效研究*

徐乾山, 徐彤, 金磊, 马多朵, 黄瑞, 曹禺彤   

  1. 215000 江苏省苏州市高新区人民医院放射科(徐乾山,徐彤,马多朵,黄瑞);介入科(金磊);南京医科大学第一附属医院放射科(曹禺彤)
  • 收稿日期:2024-02-20 出版日期:2024-07-10 发布日期:2024-07-10
  • 通讯作者: 黄瑞,E-mail:258464306@qq.com
  • 作者简介:徐乾山,男,35岁,大学本科,住院医师。E-mail:sndfsk123@163.com
  • 基金资助:
    *江苏省卫生健康委员会科研项目(编号:LKM2022044)

Evaluation of blood supply and hepatic arterial embolization efficacy by CT enhanced scan in patients with hepatic hemangioma

Xu Qianshan, Xu Tong, Jin Lei, et al   

  1. Department of Radiology, People's Hospital, High-Tech Zone of Suzhou 215000, Jiangsu Province, China
  • Received:2024-02-20 Online:2024-07-10 Published:2024-07-10

摘要: 目的 分析计算机断层(CT)增强扫描评估肝血管瘤(HH)血供分型和经导管肝动脉栓塞(HAE)治疗的疗效。方法 2017年12月~2021年1月我院收治的HH患者127例,均接受CT平扫和增强扫描,测量动脉期强化比率并评估HH血供分型。所有患者均接受HAE治疗,随访3年。记录富血供与乏血供HH瘤体缩小率和动脉期强化比率缩小率。结果 在127例HH患者中,增强CT扫描诊断富血供54例和乏血供73例;在54例富血供HH病灶,均匀强化18例,不均匀强化25例,静脉期和延迟期为持续强化,11例在三期增强扫描过程中均无明显强化;富血供HH动脉期强化比率为(43.1±13.6)%,显著大于乏血供病灶【(16.5±3.7)%,P<0.05】,直径>10 cm的富血供病灶比例为9.3%,显著低于乏血供病灶的64.4%(P<0.05);在随访第2和第3年,富血供病灶瘤体缩小率分别为(32.6±7.1)%和(53.9±10.2)%,动脉期强化比率缩小率分别为(21.8±2.4)%和(27.5±3.1)%,均显著大于乏血供病灶【分别为(21.5±4.9)%和(34.7±6.9)%,和(14.2±2.5)%和(19.6±2.7)%,P<0.05】。结论 采用HAE治疗富血供HH效果显著优于乏血供病灶,术前采用CT增强扫描评估HH血供情况有助于指导治疗方法的选择和疗效评估,值得继续研究。

关键词: 肝血管瘤, 计算机断层扫描, 血供, 肝动脉栓塞术, 治疗

Abstract: Objective This study was conducted to evaluate blood supply and hepatic arterial embolization (HAE) efficacy by enhanced computed tomography (CT) in patients with hepatic hemangioma (HH). Methods 127 consecutive patients with HH were encountered in our hospital between December 2017 and January 2021, and all patients underwent CT plain and enhanced scan to measure arterial phase enhancement ratio and evaluate blood supply of HH. All patients were treated with HAE, followed-up for 3 years, and reduction rate of tumor size and arterial phase enhancement rate of HH were compared. Results Of 127 patients with HH, enhanced CT scan found rich blood supply lesions in 54 cases and poor blood supply lesions in 73 cases; of 54 lesions with rich blood supply, uniform enhancement at arterial stage in 18 cases, uneven enhancement in 25 cases, continuously enhanced at venous and delayed stage, and not enhanced at three-stages in 11 cases; enhancement rate at arterial stage in HH lesions with rich blood supply was(43.1±13.6)%, much higher than [(16.5±3.7)%, P<0.05] in lesions with poor blood supply, and percentage of greater than 10 cm lesions was 9.3%, much lower than 64.4%(P<0.05) in lesions with poor blood supply; by two and three years of follow-up, reduction rates of tumors with rich blood supply were(32.6±7.1)% and (53.9±10.2)%, and reduction rates of arterial stage enhancement were (21.8±2.4)% and (27.5±3.1)%, all significantly higher than [(21.5±4.9)% and (34.7±6.9)%, and (14.2±2.5)% and (19.6±2.7)%, P<0.05] in lesions with poor blood supply. Conclusion Efficacy of HAE in dealing with HH with rich blood supply is better than those with poor blood supply, and evaluation of blood supply of HH by CT enhanced scan before operation might help make choice of measures and warrants further investigation.

Key words: Hepatic hemangioma, Computed tomography, Blood supply, Hepatic arterial embolization, Therapy